{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:19Z","timestamp":1786980259330,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00467-020-04829-4","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T18:02:57Z","timestamp":1605636177000},"page":"1499-1509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage"],"prefix":"10.1007","volume":"36","author":[{"given":"Mariana","family":"Luna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Kamariski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliana","family":"Principi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Bocanegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia G.","family":"Vall\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"4829_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.arcped.2017.12.005","volume":"25","author":"M Oualha","year":"2018","unstructured":"Oualha M, Pierrepont S, Krug P, Gitiaux C, Hubert P, Lesage F, Salomon R (2018) Postdiarrheal hemolytic and uremic syndrome with severe multiorgan involvement and associated early risk factors. Arch Pediatr 25:118\u2013125","journal-title":"Arch Pediatr"},{"key":"4829_CR2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0022-3476(64)80337-1","volume":"54","author":"C Gianantonio","year":"1964","unstructured":"Gianantonio C, Vitaco M, Mendilaharzu F, Rutty A, Mendilaharzu J (1964) The hemolytic uremic syndrome. J Pediatr 54:478\u2013491","journal-title":"J Pediatr"},{"key":"4829_CR3","unstructured":"Bolet\u00edn Integrado de Vigilancia N\u00b0 344\u2013SE 3\u2013Enero de 2017. Available online: http:\/\/www.msal.gob.ar\/images\/stories\/boletines\/Boletin-Integrado-De-Vigilancia-N344-SE3"},{"key":"4829_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3201\/eid1405.071050","volume":"14","author":"M Rivas","year":"2008","unstructured":"Rivas M, Sosa-Estani S, Rangel J, Caletti MG, Vall\u00e9s P, Rold\u00e1n CD, Balbi L, Marsano de Mollar MC, Amoedo D, Miliwebsky E, Chinen I, Hoekstra RM, Mead P, Griffin PM (2008) Risk Factors for sporadic shiga toxin\u2013producing Escherichia coli infections in children, Argentina). Emerg Infect Dis 14:763\u2013771","journal-title":"Emerg Infect Dis"},{"key":"4829_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0140-6736(83)91795-6","volume":"1","author":"MA Karmali","year":"1983","unstructured":"Karmali MA, Steele BT, Petric M, Lim C (1983) Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1:619\u2013620","journal-title":"Lancet"},{"key":"4829_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/fpd.2006.3.88","volume":"3","author":"M Rivas","year":"2006","unstructured":"Rivas M, Miliwebsky E, Chinen I, Rold\u00e1n CD, Balbi L, Garc\u00eda B, Fiorilli G, Sosa-Estani S, Kincaid J, Rangel J, Griffin PM, Case-Control Study Group (2006) Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. Foodborne Pathog Dis 3:88\u201396","journal-title":"Foodborne Pathog Dis"},{"key":"4829_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/toxins11100607","volume":"11","author":"GAM Tarr","year":"2019","unstructured":"Tarr GAM, Stokowski T, Shringi S, Tarr PI, Freedman S, Oltean HN, Rabinowitz PM, Chui L (2019) Contribution and interaction of Shiga toxin genes to Escherichia coli O157:H7 virulence. Toxins 11:607","journal-title":"Toxins"},{"key":"4829_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijmm.2016.02.005","volume":"306","author":"L Pianciola","year":"2016","unstructured":"Pianciola L, D\u2019Astek BA, Mazzeo M, Chinen I, Masana M, Rivas M (2016) Genetic features of human and bovine Escherichia coli O157:H7 strains isolated in Argentina. Int J Med Microbiol 306:123\u2013130","journal-title":"Int J Med Microbiol"},{"key":"4829_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.micinf.2006.10.005","volume":"9","author":"S Sch\u00fcller","year":"2007","unstructured":"Sch\u00fcller S, Heuschkel R, Torrente F, Kaper JB, Phillips AD (2007) Shiga toxin binding in normal and inflamed human intestinal mucosa. Microbes Infect 9:35\u201339","journal-title":"Microbes Infect"},{"key":"4829_CR10","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.3390\/toxins3060626","volume":"3","author":"S Sch\u00fcller","year":"2011","unstructured":"Sch\u00fcller S (2011) Shiga toxin interaction with human intestinal epithelium. Toxins 3:3626\u20133639","journal-title":"Toxins"},{"key":"4829_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00467-017-3850-x","volume":"34","author":"C Zoja","year":"2019","unstructured":"Zoja C, Buelli S, Morigi M (2019) Shiga toxin triggers endothelial and podocyte injury: the role of complement activation. Pediatr Nephrol 34:379\u2013388","journal-title":"Pediatr Nephrol"},{"key":"4829_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00467-011-2014-7","volume":"27","author":"PG Vall\u00e9s","year":"2012","unstructured":"Vall\u00e9s PG, Melechuck S, Gonz\u00e1lez A, Manucha W, Bocanegra V, Vall\u00e9s R (2012) Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome. Pediatr Nephrol 27:407\u2013415","journal-title":"Pediatr Nephrol"},{"key":"4829_CR13","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00467-017-3876-0","volume":"33","author":"R Exeni","year":"2018","unstructured":"Exeni R, Fernandez-Brando R, Santiago A, Fiorentino G, Exeni A, Ramos M, Palermo M (2018) Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 33:2057\u20132071","journal-title":"Pediatr Nephrol"},{"key":"4829_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/ped.14053","volume":"62","author":"M Shimizu","year":"2020","unstructured":"Shimizu M (2020) Pathogenic functions and diagnostic utility of cytokines\/chemokines in EHEC-HUS. Pediatr Int 62:308\u2013315","journal-title":"Pediatr Int"},{"key":"4829_CR15","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/brain\/aws090","volume":"135","author":"T Magnus","year":"2012","unstructured":"Magnus T, R\u00f6ther J, Simova O, Meier-Cillien M, Repenthin J, M\u00f6ller F, Gbadamosi J, Panzer U, Wengenroth M, Hagel C, Kluge S, Stahl R, Wegscheider K, Urban P, Eckert B, Glatzel M, Jens Fiehler J, Gerloff C (2012) The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain 135:1850\u20131859","journal-title":"Brain"},{"key":"4829_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.patbio.2015.03.001","volume":"63","author":"C Picard","year":"2015","unstructured":"Picard C, Burtey S, Bornet C, Curti C, Montana M, Vanelle P (2015) Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome. Pathol Biol (Paris) 63:136\u2013143","journal-title":"Pathol Biol (Paris)"},{"key":"4829_CR17","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, N\u00fcrnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368:2169\u20132181","journal-title":"N Engl J Med"},{"key":"4829_CR18","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1056\/NEJMc1100859","volume":"364","author":"AL Lapeyraque","year":"2011","unstructured":"Lapeyraque AL, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M, Proulx F, Clermont MJ, Le Deist F, Niaudet P, Schaefer F (2011) Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 364:2561\u20132563","journal-title":"N Engl J Med"},{"key":"4829_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N, KDIGO AKI Guideline Work Group (2013) KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17:204","journal-title":"Crit Care"},{"key":"4829_CR20","first-page":"395","volume":"65","author":"PG Vall\u00e9s","year":"2005","unstructured":"Vall\u00e9s PG, Pesle S, Piovano L, Davila E, Peralta M, Principi I, Lo Giudice P (2005) Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock. Medicina (B Aires) 65:395\u2013401","journal-title":"Medicina (B Aires)"},{"key":"4829_CR21","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1097\/CCM.0b013e31828a24a8","volume":"41","author":"SA Braune","year":"2013","unstructured":"Braune SA, Wichmann D, von Heinz MC, Nierhaus A, Becker H, Meyer TN, Meyer GP, M\u00fcller-Schulz M, Fricke J, de Weerth A, Hoepker WW, Fiehler J, Magnus T, Gerloff C, Panzer U, Stahl RAK, Wegscheider K, Kluge S (2013) Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome. Crit Care Med 41:1702\u20131710","journal-title":"Crit Care Med"},{"key":"4829_CR22","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1097\/00003246-200107001-00036","volume":"29","author":"D Annane","year":"2001","unstructured":"Annane D (2001) Corticosteroids for septic shock. Crit Care Med 29:S117\u2013S120","journal-title":"Crit Care Med"},{"key":"4829_CR23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/neu.2011.2272","volume":"29","author":"SR Beers","year":"2012","unstructured":"Beers SR, Wisniewski SR, Garcia-Filion P, Tian Y, Hahner T, Berger RP, Bell M, Adelson PD (2012) Validity of a pediatric version of the Glasgow outcome scale-extended. J Neurotrauma 29:1126\u20131139","journal-title":"J Neurotrauma"},{"key":"4829_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.vetmic.2009.04.011","volume":"140","author":"MA Karmali","year":"2010","unstructured":"Karmali MA, Gannon V, Sargeant JM (2010) Verocytotoxin-producing Escherichia coli (VTEC). Vet Microbiol 140:360\u2013370","journal-title":"Vet Microbiol"},{"key":"4829_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","volume":"390","author":"F Fakhouri","year":"2017","unstructured":"Fakhouri F, Zuber J, Fr\u00e9meaux-Bacchi V, Loirat C (2017) Haemolytic uraemic syndrome. Lancet 390:681\u2013696","journal-title":"Lancet"},{"key":"4829_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.EHEC-0002-2013","volume":"2","author":"M Rivas","year":"2014","unstructured":"Rivas M, Chinen I, Miliwebsky E, Masana M (2014) Risk factors for Shiga toxin-producing Escherichia coli-associated human diseases. Microbiol Spectr 2:1\u201314","journal-title":"Microbiol Spectr"},{"key":"4829_CR27","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1056\/NEJMoa1106482","volume":"365","author":"U Buchholz","year":"2011","unstructured":"Buchholz U, Bernard H, Werber D, B\u00f6hmer MM, Remschmidt C, Wilking H, Deler\u00e9 Y, an der Heiden M, Adlhoch C, Dreesman J, Ehlers J, Ethelberg S, Faber M, Frank C, Fricke G, Greiner M, H\u00f6hle M, Ivarsson S, Jark U, Kirchner M, Koch J, Krause G, Luber P, Rosner B, Stark K, K\u00fchne M (2011) German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med 365:1763\u20131770","journal-title":"N Engl J Med"},{"key":"4829_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/microorganisms6040100","volume":"6","author":"AG Torres","year":"2018","unstructured":"Torres AG, Amaral MM, Bentancor L, Galli L, Goldstein J, Kr\u00fcger A, Rojas-Lopez M (2018) Recent advances in Shiga toxin-producing Escherichia coli research in Latin America. Microorganisms 6:100","journal-title":"Microorganisms"},{"key":"4829_CR29","doi-asserted-by":"publisher","first-page":"EHEC-0019\u20132013","DOI":"10.1128\/microbiolspec.EHEC-0019-2013","volume":"2","author":"F Scheutz","year":"2014","unstructured":"Scheutz F (2014) Taxonomy meets public health: the case of Shiga toxin-producing Escherichia coli. Microbiol Spectr 2:EHEC-0019\u20132013","journal-title":"Microbiol Spectr"},{"key":"4829_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/toxins12020067","volume":"12","author":"A Joseph","year":"2020","unstructured":"Joseph A, Cointe A, Kurkdjian PM, Rafat C, Hertig A (2020) Shiga toxin-associated hemolytic uremic syndrome: a narrative review. Toxins (Basel) 12:67","journal-title":"Toxins (Basel)"},{"key":"4829_CR31","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00467-018-4105-1","volume":"34","author":"M Khalid","year":"2019","unstructured":"Khalid M, Andreoli S (2019) Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS). Pediatr Nephrol 34:2495\u20132507","journal-title":"Pediatr Nephrol"},{"key":"4829_CR32","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1136\/adc.2006.109363","volume":"92","author":"MA Anjay","year":"2007","unstructured":"Anjay MA, Anoop P, Britland A (2007) Leukocytosis as a predictor for progression to haemolytic uraemic syndrome in Escherichia coli O157:H7 infection. Arch Dis Child 92:820\u2013823","journal-title":"Arch Dis Child"},{"key":"4829_CR33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/00006454-200007000-00012","volume":"19","author":"C Buteau","year":"2000","unstructured":"Buteau C, Proulx F, Chaibou M, Raymond D, Clermont MJ, Mariscalco MM, Lebel MH, Seidman E (2000) Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome. Pediatr Infect Dis J 19:642\u2013647","journal-title":"Pediatr Infect Dis J"},{"key":"4829_CR34","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s00467-018-3991-6","volume":"33","author":"L Alconcher","year":"2018","unstructured":"Alconcher L, Coccia P, Suarez A, Monteverde M, Perez M (2018) Hyponatremia: a new predictor of mortality in patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome. Pediatr Nephrol 33:1791\u20131798","journal-title":"Pediatr Nephrol"},{"key":"4829_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12879-016-1627-7","volume":"16","author":"GR Jenssen","year":"2016","unstructured":"Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nyg\u00e5rd K, Bjerre A (2016) Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008. BMC Infect Dis 16:285","journal-title":"BMC Infect Dis"},{"key":"4829_CR36","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2215\/CJN.08921209","volume":"5","author":"S Nathanson","year":"2010","unstructured":"Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, Brun M, Ranchin B, Bandin F, Cloarec S, Bourdat-Michel G, Pi\u00e8trement C, Champion G, Ulinski T, Desch\u00eanes G (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5:1218\u20131228","journal-title":"Clin J Am Soc Nephrol"},{"key":"4829_CR37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1160\/TH09-11-0771","volume":"104","author":"AP Owens","year":"2010","unstructured":"Owens AP, Mackman N (2010) Tissue factor and thrombosis: the clot starts here. Thromb Haemost 104:432\u2013439","journal-title":"Thromb Haemost"},{"key":"4829_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.micpath.2003.11.004","volume":"36","author":"PB Eisenhauer","year":"2004","unstructured":"Eisenhauer PB, Jacewicz MS, Conn KJ, Koul O, Wells JM, Fine RE (2004) Escherichia coli Shiga toxin 1 and TNF-alfa induce cytokine release by human cerebral micro- vascular endothelial cells. Microb Pathog 36:189\u2013196","journal-title":"Microb Pathog"},{"key":"4829_CR39","first-page":"5","volume":"21","author":"K Takahashi","year":"2008","unstructured":"Takahashi K, Funata N, Ikuta F, Sato S (2008) Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. Neuroinflammation 21:5\u201311","journal-title":"Neuroinflammation"},{"key":"4829_CR40","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.4049\/jimmunol.1402470","volume":"194","author":"I Arvidsson","year":"2015","unstructured":"Arvidsson I, St\u00e5hl AL, Hedstr\u00f6m MM, Kristoffersson AC, Rylander C, Westman JS, Storry JR, Olsson ML, Karpman D (2015) Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome. J Immunol 194:2309\u20132318","journal-title":"J Immunol"},{"key":"4829_CR41","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","volume":"117","author":"A St\u00e5hl","year":"2011","unstructured":"St\u00e5hl A, Sartz L, Karpman D (2011) Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood 117:5503\u20135513","journal-title":"Blood"},{"key":"4829_CR42","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","volume":"182","author":"D Orth","year":"2009","unstructured":"Orth D, Khan AB, Naim A, Grif K, Brockmeyer J, Karch H, Joannidis M, Clark SJ, Day AJ, Fidanzi S, Stoiber H, Dierich MP, Zimmerhackl LB, W\u00fcrzner R (2009) Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 182:6394\u20136400","journal-title":"J Immunol"},{"key":"4829_CR43","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/cid\/cis196","volume":"54","author":"A Rosales","year":"2012","unstructured":"Rosales A, Hofer J, Zimmerhackl LB, Jungraithmayr TC, Riedl M, Giner T, Strasak A, Orth-H\u00f6ller D, W\u00fcrzner R, Karch H, German-Austrian HUS Study Group (2012) Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late emerging sequelae. Clin Infect Dis 54:1413\u20131421","journal-title":"Clin Infect Dis"},{"key":"4829_CR44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s004670050248","volume":"11","author":"FD Spizzirri","year":"1997","unstructured":"Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR (1997) Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 11:156\u2013160","journal-title":"Pediatr Nephrol"},{"key":"4829_CR45","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fped.2018.00220","volume":"6","author":"L Vaterodt","year":"2018","unstructured":"Vaterodt L, Holle J, H\u00fcseman D, M\u00fcller D, Thumfart J (2018) Short- and long-term renal outcome of hemolytic-uremic syndrome in childhood. Front Pediatr 6:220","journal-title":"Front Pediatr"},{"key":"4829_CR46","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00431-016-2790-y","volume":"175","author":"D Rigamonti","year":"2016","unstructured":"Rigamonti D, Simonetti GD (2016) Direct cardiac involvement in childhood hemolytic-uremic syndrome: case report and review of the literature. Eur J Pediatr 175:1927\u20131931","journal-title":"Eur J Pediatr"},{"key":"4829_CR47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0022-3476(94)70002-8","volume":"125","author":"JR Brandt","year":"1994","unstructured":"Brandt JR, Fouser LS, Watkins SL, Zelikovic I, Tarr PI, Nazar-Stewart V, Avner ED (1994) Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers. J Pediatr 125:519\u2013526","journal-title":"J Pediatr"},{"key":"4829_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF00858990","volume":"9","author":"EG Gallo","year":"1995","unstructured":"Gallo EG, Gianantonio CA (1995) Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome. Pediatr Nephrol 9:117\u2013119","journal-title":"Pediatr Nephrol"},{"key":"4829_CR49","first-page":"195","volume":"6","author":"LS Keir","year":"2012","unstructured":"Keir LS, Marks SD, Kim JJ (2012) Shiga toxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des Devel Ther 6:195\u2013208","journal-title":"Drug Des Devel Ther"},{"key":"4829_CR50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/archdischild-2016-311377","volume":"103","author":"PR Walsh","year":"2018","unstructured":"Walsh PR, Johnson S (2018) Treatment and management of children with haemolytic uraemic sindrome. Arch Dis Child 103:285\u2013291","journal-title":"Arch Dis Child"},{"key":"4829_CR51","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/cid\/cix218","volume":"64","author":"S Loos","year":"2017","unstructured":"Loos S, Aulbert W, Hoppe B, Ahlenstiel-Grunow T, Kranz B, Wahl C, Staude H, Humberg A, Benz K, Krause M, Pohl M, Liebau MC, Schild R, Lemke J, Beringer O, M\u00fcller D, H\u00e4rtel C, Wigger M, Vester U, Konrad M, Haffner D, Pape L, Oh J, Kemper MJ (2017) Intermediate follow-up of pediatric patients with hemolytic uremic syndrome during the 2011 outbreak caused by E. coli O104:H4. Clin Infect Dis 64:1637\u20131643","journal-title":"Clin Infect Dis"},{"key":"4829_CR52","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1093\/ndt\/gfr462","volume":"26","author":"The German EHEC-HUS Registry","year":"2011","unstructured":"The German EHEC-HUS Registry (2011) The German 2011 epidemic of Escherichia coli O157:H7 infections: association with intravenous Shiga toxin-producing E. coli\u2014the nephrological view. Nephrol Dial Transplant 26:2723\u20132726","journal-title":"Nephrol Dial Transplant"},{"key":"4829_CR53","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","volume":"290","author":"AX Garg","year":"2003","unstructured":"Garg AX, Suri RS, Barrowman N, Rehman N, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF (2003) Long-term renal prognosis of diarrhea-associated hemolytic suremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290:1360\u20131370","journal-title":"JAMA"},{"key":"4829_CR54","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/1744-9987.12768","volume":"23","author":"W Keenswijk","year":"2019","unstructured":"Keenswijk W, Raes A, De Clerck M, Vande Walle J (2019) Is plasma exchange efficacious in Shiga toxin-associated hemolytic uremic syndrome? A narrative review of current evidence. Ther Apher Dial 23:118\u2013125","journal-title":"Ther Apher Dial"},{"key":"4829_CR55","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0140-6736(11)61145-8","volume":"378","author":"E Colic","year":"2011","unstructured":"Colic E, Dieperink H, Titlestad K, Tepel M (2011) Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study. Lancet 378:1089\u20131093","journal-title":"Lancet"},{"key":"4829_CR56","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0140-6736(11)61217-8","volume":"378","author":"P Ruggenenti","year":"2011","unstructured":"Ruggenenti P, Remuzzi G (2011) A German out-break of haemolytic uraemic syndrome. Lancet 378:1057\u20131058","journal-title":"Lancet"},{"key":"4829_CR57","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/INF.0000000000000425","volume":"33","author":"M Mor","year":"2014","unstructured":"Mor M, Ashkenazi S (2014) The dilemma of antimicrobia ltreatment of Shiga toxin-producing Escherichia coli. Pediatr Infect Dis J 33:979\u2013981","journal-title":"Pediatr Infect Dis J"},{"key":"4829_CR58","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jama.2012.264","volume":"307","author":"M Nitschke","year":"2012","unstructured":"Nitschke M, Sayk F, H\u00e4rtel C, Roseland RT, Hauswaldt S, Steinhoff J, Fellermann K, Derad I, Wellh\u00f6ner P, B\u00fcning J, Tiemer B, Katalinic A, Rupp J, Lehnert H, Solbach W, Knobloch JK (2012) Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin\u2013producing Enteroaggregative Escherichia coli O104:H4. JAMA 307:1046\u20131052","journal-title":"JAMA"},{"key":"4829_CR59","doi-asserted-by":"publisher","first-page":"e4565","DOI":"10.1136\/bmj.e4565","volume":"345","author":"J Menne","year":"2012","unstructured":"Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenm\u00fcller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, M\u00fcnte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Sch\u00f6cklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellh\u00f6ner P, Wiesner M, Zeissig S, B\u00fcning J, Schiffer M, Kuehbacher T, EHEC-HUS consortium (2012) Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 345:e4565","journal-title":"BMJ"},{"key":"4829_CR60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/cid\/cis299","volume":"55","author":"CS Wong","year":"2012","unstructured":"Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR (2012) Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 55:33\u201341","journal-title":"Clin Infect Dis"},{"key":"4829_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s004670050413","volume":"12","author":"N Perez","year":"1998","unstructured":"Perez N, Spizzirri F, Rahman R, Suarez A, Larrubia C, Lasarte P (1998) Steroids in the hemolytic uremic syndrome. Pediatr Nephrol 12:101\u2013104","journal-title":"Pediatr Nephrol"},{"key":"4829_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41420-017-0007-4","volume":"4","author":"K Yahiro","year":"2018","unstructured":"Yahiro K, Nagasawa S, Ichimura K, Takeuchi H, Ogura K, Tsutsuki H, Shimizu T (2018) Mechanism of inhibition of Shiga-toxigenic Escherichia coli SubAB cytotoxicity by steroids and diacylglycerol analogues. Cell Death Dis 4:22","journal-title":"Cell Death Dis"},{"key":"4829_CR63","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ijmm.2018.09.007","volume":"308","author":"A Pinto","year":"2018","unstructured":"Pinto A, Berdasco C, Arenas-Mosquera D, Cangelosi A, Geoghegan PA, Nu\u00f1ez MC, Goldstein J (2018) Anti-inflammatory agents reduce microglial response, demyelinating process and neuronal toxin uptake in a model of encephalopathy produced by Shiga toxin 2. Int J Med Microbiol 308:1036\u20131042","journal-title":"Int J Med Microbiol"},{"key":"4829_CR64","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1164\/ajrccm.163.7.2012022","volume":"163","author":"Y Shenker","year":"2001","unstructured":"Shenker Y, Skatrud JB (2001) Adrenal insufficiency in critically ill patients. Am J Respir Crit Care Med 163:1520\u20131523","journal-title":"Am J Respir Crit Care Med"},{"key":"4829_CR65","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","volume":"23","author":"L Cronin","year":"1995","unstructured":"Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, Fisher CJ (1995) Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23:1430\u20131439","journal-title":"Crit Care Med"},{"key":"4829_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/microorganisms7010015","volume":"7","author":"S Buelli","year":"2019","unstructured":"Buelli S, Zoja C, Remuzzi G, Morigi M (2019) Complement activation contributes to the pathophysiology of Shiga toxin-associated hemolytic uremic syndrome. Microorganisms 7:15","journal-title":"Microorganisms"},{"key":"4829_CR67","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00467-018-3903-9","volume":"33","author":"L Percheron","year":"2018","unstructured":"Percheron L, Gramada R, Tellier S, Salomon R, Harambat J (2018) Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study. Pediatr Nephrol 33:1385\u20131394","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04829-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T08:10:42Z","timestamp":1650528642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04829-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["4829"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04829-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Pediatric Notti Hospital\u2019s Teaching and Research Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}